{"disease":{"id":"puberty-disorders","name":"puberty disorders"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03283852","title":"Identifying New Genetic Causes to Development Disorders","phase":"","overall_status":"RECRUITING","enrollment_count":1100,"lead_sponsor_name":"Fondation Ophtalmologique Adolphe de Rothschild","has_results":false},{"nct_id":"NCT07359092","title":"Spexin and Phoenixin-20 in Girls With Central Precocious Puberty","phase":"","overall_status":"COMPLETED","enrollment_count":143,"lead_sponsor_name":"Kayseri City Hospital","has_results":false},{"nct_id":"NCT05033574","title":"The State of Sexual Development in Children With Inherited Epidermolysis Bullosa","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"National Medical Research Center for Children's Health, Russian Federation","has_results":false},{"nct_id":"NCT04075149","title":"Does Treatment of Androgen Excess Using Spironolactone Improve Ovulatory Rates in Girls With Androgen Excess?","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":24,"lead_sponsor_name":"University of Virginia","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}